SpineGuard SA (EPA:ALSGD)
France
· Delayed Price · Currency is EUR 0.0986
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
SpineGuard Revenue
In the year 2025, SpineGuard had annual revenue of 3.76M EUR, down -19.16%. SpineGuard had revenue of 1.64M in the half year ending December 31, 2025, a decrease of -21.25%.
Revenue
3.76M
Revenue Growth
-19.16%
P/S Ratio
2.46
Revenue / Employee
250.48K
Employees
15
Market Cap
9.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76M | -890.77K | -19.16% |
| Dec 31, 2024 | 4.65M | 335.24K | 7.77% |
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bluelinea Société Anonyme | 11.68M |
| Biosynex | 97.95M |
| Mauna Kea Technologies | 8.91M |
| Ikonisys | 1.47M |
| Novacyt | 22.69M |
| Theraclion | 2.32M |
| Implanet | 12.47M |
| Diagnostic Medical Systems | 49.47M |